- Home
- THRD vs GAU Comparison
THRD vs GAU Comparison
Compare THRD & GAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- GAU
- Stock Information
- Founded
- THRD 2019
- GAU 1999
- Country
- THRD United States
- GAU Canada
- Employees
- THRD N/A
- GAU N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- GAU
- Sector
- THRD Health Care
- GAU
- Exchange
- THRD Nasdaq
- GAU Nasdaq
- Market Cap
- THRD 157.7M
- GAU 323.9M
- IPO Year
- THRD 2022
- GAU N/A
- Fundamental
- Price
- THRD $3.45
- GAU $1.34
- Analyst Decision
- THRD Buy
- GAU Strong Buy
- Analyst Count
- THRD 3
- GAU 2
- Target Price
- THRD $14.00
- GAU $2.53
- AVG Volume (30 Days)
- THRD 435.5K
- GAU 799.8K
- Earning Date
- THRD 03-25-2025
- GAU 05-01-2025
- Dividend Yield
- THRD N/A
- GAU N/A
- EPS Growth
- THRD N/A
- GAU N/A
- EPS
- THRD N/A
- GAU N/A
- Revenue
- THRD N/A
- GAU $166,788,000.00
- Revenue This Year
- THRD N/A
- GAU N/A
- Revenue Next Year
- THRD N/A
- GAU $44.80
- P/E Ratio
- THRD N/A
- GAU N/A
- Revenue Growth
- THRD N/A
- GAU N/A
- 52 Week Low
- THRD $3.18
- GAU $1.05
- 52 Week High
- THRD $16.94
- GAU $2.00
- Technical
- Relative Strength Index (RSI)
- THRD 30.03
- GAU 60.31
- Support Level
- THRD $3.36
- GAU $1.14
- Resistance Level
- THRD $3.65
- GAU $1.29
- Average True Range (ATR)
- THRD 0.14
- GAU 0.07
- MACD
- THRD 0.16
- GAU 0.01
- Stochastic Oscillator
- THRD 35.48
- GAU 96.04
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About GAU Galiano Gold Inc.
Galiano Gold Inc is focused on building a sustainable business capable of long term value creation for its stakeholders through a combination of exploration, accretive acquisitions, and disciplined deployment of its financial resources. The company currently operates and manages the Asanko Gold Mine, located in Ghana, West Africa. Its Asanko Gold Mine is a multi-deposit complex, with two main deposits, the Obotan Project and the Esaase Project, both located in the Amansie West District of the Republic of Ghana, West Africa.